18 F-FET PET Compared with 18 F- FDG PET and CT in Patients with Head and Neck Cancer Present by Intern 羅穎駿 Journal of Nuclear Medicine Vol. 47 No. 2 256-261.

Slides:



Advertisements
Similar presentations
CLINICAL USE OF SPECT-CT IN BREAST & PROSTATE CANCERS
Advertisements

Yasir Rudha, MD; Amr Aref, MD; Paul Chuba, MD; Kevin O’Brien, MD
Hong CM, Ahn BC, Jeong SY, Lee SW, Lee J
FDG-PET/CT PATTERNS AND PREVALENCE OF PERITONEAL SPREAD IN OVARIAN CANCER Srour SF 1, Bar-Shalom R 2 Srour SF 1, Bar-Shalom R 2 1 Department of Diagnostic.
The Thyroid Incidentaloma
EDWARD WEISBERGER MD OTOLARYNGOLOGY/HEAD AND NECK SURGERY INDIANA UNIVERSITY MEDICAL CENTER.
“International Conference on Clinical PET and Molecular Nuclear Medicine” IAEA - IPET 2007 Bangkok, Thailand 10 to 14 November 2007 C. Suarez, R. Pruzzo,
Clinical Significance of Preoperative 18F-FDG PET Non- Avidity in Papillary Thyroid Carcinoma Do Hoon Koo 1, Ho-Young Lee 2, Kyu Eun Lee 3,4, So Won Oh.
Overskrift her Navn på oplægsholder Navn på KU- enhed For at ændre ”Enhedens navn” og ”Sted og dato”: Klik i menulinjen, vælg ”Indsæt” > ”Sidehoved / Sidefod”.
18F- FDG PET/CT in the Diagnosis of Tumor Thrombosis
Is the BRAF V600E mutation useful as a predictor of preoperative risk in papillary thyroid cancer? The American Journal of Surgery.
Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence Manuel Gómez-Río & Antonio Rodríguez-Fernández.
Total Lesion Glycolysis by 18 F-FDG PET/CT a Reliable Predictor of Prognosis in Soft Tissue Sarcoma Ilkyu Han Musculoskeletal Tumor Center, Seoul National.
Application of Positron Emission Tomography ( PET ) in Colorectal Cancer Dr Chan Wai Keung Department of Surgery Ruttonjee and Tang Shiu Kin Hospitals.
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Breast Cancer Early detection of disease Precise Staging.
Steven M. Larson, M.D. Memorial Sloan Kettering Cancer Center
Update on 18 F-Fluorodeoxyglucose/Positron Emission Tomography and Positron Emission Tomography/ Computed Tomography Imaging of Squamous Head and Neck.
Integrated PET/CT in Differentiated Thyroid Cancer: Diagnostic Accuracy and Impact on Patient Management J Nucl Med 2006; 47:616–624 報告者 : 蘇惠怡.
The Detection of Bone Metastases in Patients with High-Risk Prostate Cancer: 99 mTc-MDP Planar Bone Scintigraphy, Single- and Multi-Field-of-View SPECT,
Dual-time point 18F-FDG PET/CT scan: is it always working?
Results of an Ontario Clinical Oncology Group (OCOG) prospective cohort study on the use of FDG PET/CT to predict the need for.
DAHANCA 16 Planned post-radiation neck dissection vs salvage neck dissection in patients with N2-3 SCC of the head and neck treated with primary radiotherapy.
M. Wissmeyer Department of Nuclear Medicine, University of Berne (Inselspital) PET/CT in Oncology: PET Tracers other than FDG.
Functional Imaging with PET for Sarcoma Rodney Hicks, MD, FRACP Director, Centre for Molecular Imaging Guy Toner, MD, FRACP Director, Medical Oncology.
radio-iodinated metaiodobenzylguanidine (123I-MIBG)
Neck Cancer Head and STATEMENTS ON January 28, 2006 Frankfurt am Main, Germany Surgery Management of Lymph Node Metastases.
PET in Colorectal Cancer. Indications for FDG PET Rising marker, (-) CT/MRI Nonspecific findings on CT/MRI, recurrence or post treatment changes? Known.
Definitive radiotherapy for head and neck cancer: the use of physical exam versus computed tomography to manage the post-RT neck Stanley Liauw*, Robert.
11th Biennial Meeting of the International Gynecologic Cancer Society 11th Biennial Meeting of the International Gynecologic Cancer Society Semih Gorgulu,
December Rontgen’s wife’s hand. The first Xray.
Prognostic Value of PET Using 18F-FDG in Hodgkin’s Disease for Posttreatment Evaluation J Nucl Med 2003; 44:1225–1231 Intern 魏敬庭.
Grading And Staging Grading is based on the microscopic features of the cells which compose a tumor and is specific for the tumor type. Staging is based.
Tha role of FDG-PET for Mediastinal Staging in Primary Lung Cancer
ACRIN 6682 Phase II Trial OF 64 Cu-ATSM PET/CT in Cervical Cancer Principal Investigator: Farrokh Dehdashti, MD 10/4/08.
Albert J. Chang, MD, PhD 1 Farrokh Dehdashti, MD 2 Perry W. Grigsby, MD, MS 1 Department of Radiation Oncology 1 Department of Radiology and Nuclear Medicine.
PET/MR in Oncology: Non– 18 F- FDG Tracers for Routine Applications R2 丁建鑫.
1. What is your clinical impression?. Differential Diagnosis TB adenopathyLymphoma Lymphadenitis from aphthous ulcer Metastatic carcinoma from oral cavity.
Anaplastic thyroid cancer based on ATA guideline for Management of Patients with ATC. Thyroid. 2012;22: R3 이정록.
IMAGING OF INCIDENTAL ADRENAL LESIONS: PRINCIPLES, TECHNIQUES AND ALGORITHMS Giles W.L. Boland Massachusetts General Hospital Harvard Medical School.
Preoperative staging of hilar cholangiocarcinoma by dual-modality PET/CT. DR SIKANDAR YASHODA HOSPITALS HYDERABAD.
Annals of Oncology 23: 298–304, 2012 종양혈액내과 R4 김태영 / prof. 김시영.
Supraclavicular metastasis from urothelial bladder carcinoma: A case report S. Farmahan, T. Mirza, P. Ameerally Oral Maxillofacial Department, Northampton.
JESÚS SILVA-RODRÍGUEZ, PABLO AGUIAR, INÉS DOMÍNGUEZ-PRADO, MICHEL HERRANZ, ÁLVARO RUIBAL 18F-Choline: Is shine-through effect an issue for prostate SUV.
간담도 암에서의 PET 의 활용 핵의학과 홍일기. 18 F-FDG PET: Warburg effect.
Date of download: 6/27/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Diagnostic Accuracy of Colorectal Cancer Staging.
Background: Malignant pleural mesothelioma (MPM) is a rare and aggressive tumor with a complex growth pattern. Imaging plays a crucial role in diagnosis.
DEPT OF RADIATION ONCOLOGY Prognostic Value of Post-Radiotherapy FDG PET in Head and Neck Cancer after Intensity Modulated Radiation Treatment Heming Lu.
University of Pennsylvania Department of Orthopaedic Surgery Joseph King, Eileen Crawford, Abass Alavi, Arthur Staddon, Lee Hartner, Richard Lackman and.
Nuclear imaging for prostate cancer: What’s new?
Klinikum rechts der Isar, Technische Universität München
Correlation of tumor blood volume and apparent diffusion coefficient values with the prognostic parameters of head and neck squamous cell carcinoma Abdel.
PET Applications in Oncology 2015/2016
CT and PET imaging in non-small cell lung cancer
CORRELATION OF PHYSICAL EVALUATION AND MRI OF CERVICAL LYMPH NODE WITH HISTOPATHOLOGICAL FINDINGS IN ORAL SQUAMOUS CELL CARCINOMA: AN AMBIDIRECTIONAL STUDY.
Zehra Nihal Dolgun, Ahmet Salih Altintas, Cihan Inan, Petek Balkanli
FDG PET-CT of Genitourinary and Gynecologic Tumors: Overcoming the Challenges of Evaluating the Abdomen and Pelvis  Leslie K. Lee, MD, Aoife Kilcoyne,
Helle-Brit Fiebrich, Sophie J. van Asselt, Adrienne H
Michael Lin, Jenn Hian Koo, David Abi–Hanna 
Applications of Diagnostic Imaging Nuclear Medicine
FDG PET-CT Aids in the Preoperative Assessment of Patients with Newly Diagnosed Thymic Epithelial Malignancies  Marcelo F.K. Benveniste, MD, Cesar A.
Volume 4, Issue 3, Pages (April 2018)
Otolaryngology referred this patient for imaging after palpating a mass in the “left parotid tail.” Axial contrast-enhanced CT scan through the mass reveals.
Positron emission tomographic imaging with fluorodeoxyglucose is efficacious in evaluating malignant pulmonary disease  Geoffrey M. Graeber, MD*, Naresh.
The impact of 18F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: Results from Westmead Hospital, Sydney, Australia  Rebecca.
MR-PET of the body: Early experience and insights
The role of positron emission tomography for non-small cell lung cancer  Albert J. Chang, MD, PhD, Farrokh Dehdashti, MD, Jeffrey D. Bradley, MD  Practical.
A Patient With BRAF V600E Lung Adenocarcinoma Responding to Vemurafenib  Oliver Gautschi, MD, Chantal Pauli, MD, Klaus Strobel, MD, Astrid Hirschmann,
The utility of optical coherence tomography for diagnosis of basal cell carcinoma: a quantitative review N. Reddy and B.T. Nguyen Department of Dermatology,
Lack of FDG Uptake in Small Cell Carcinoma Associated with ANNA-1 Positive Paraneoplastic Autonomic Neuropathy  Matthew S. Block, MD, PhD, Robert Vassallo,
Figure 12a Pitfalls in N staging at CT and PET
Presentation transcript:

18 F-FET PET Compared with 18 F- FDG PET and CT in Patients with Head and Neck Cancer Present by Intern 羅穎駿 Journal of Nuclear Medicine Vol. 47 No © 2006

INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION CONCLUSION

INTRODUCTION Characteristics of tumor lesion: Increased glucose metabolism Increased glucose metabolism Increased DNA synthesis Increased DNA synthesis Increased amino acid transportation Increased amino acid transportation Increased presentation of some receptors and antigens Increased presentation of some receptors and antigens

INTRODUCTION Discrimination between tumor and reactive tissue changes may be difficult based solely on morphologic criteria, for example, by CT and MRI Discrimination between tumor and reactive tissue changes may be difficult based solely on morphologic criteria, for example, by CT and MRI 18 F-FDG has a sensitivity of 80% – 100% for the detection of primary tumors, tumor recurrences, and occult metastases, but is not specific for cancer cells and exhibits high uptake in macrophages, fibroblasts, and granulation tissue 18 F-FDG has a sensitivity of 80% – 100% for the detection of primary tumors, tumor recurrences, and occult metastases, but is not specific for cancer cells and exhibits high uptake in macrophages, fibroblasts, and granulation tissue

INTRODUCTION Artificial amino acid that is not incorporated into proteins but exhibits high uptake in tumor cells because of increased transport via the amino acid transport systems L and B 0,+ Artificial amino acid that is not incorporated into proteins but exhibits high uptake in tumor cells because of increased transport via the amino acid transport systems L and B 0,+ Animal experiments show that 18 F- FET, in contrast to 18 F-FDG, exhibits no uptake in inflammatory cells or in inflammatory lymph nodes Animal experiments show that 18 F- FET, in contrast to 18 F-FDG, exhibits no uptake in inflammatory cells or in inflammatory lymph nodes

INTRODUCTION Squamous cell carcinoma (SCC) is the major histologic type of the head and neck neoplasm Squamous cell carcinoma (SCC) is the major histologic type of the head and neck neoplasm Selective uptake of O-(2- [18F]fluoroethyl)-L-tyrosine (FET) in cerebral gliomas and in SCC Selective uptake of O-(2- [18F]fluoroethyl)-L-tyrosine (FET) in cerebral gliomas and in SCC Good distinction between tumor and inflammation Good distinction between tumor and inflammation

INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION CONCLUSION

MATERIALS AND METHODS Twenty-one patients (3 women and 18 men; age range, 41 – 80 y; mean, 61 y) with suspected head and neck tumors underwent 18 F-FET PET, 18 F-FDG PET, and CT within 1 wk before operation Twenty-one patients (3 women and 18 men; age range, 41 – 80 y; mean, 61 y) with suspected head and neck tumors underwent 18 F-FET PET, 18 F-FDG PET, and CT within 1 wk before operation After coregistration, the images were evaluated by 3 independent observers and an ROC analysis was performed, with the histopathologic result used as a reference After coregistration, the images were evaluated by 3 independent observers and an ROC analysis was performed, with the histopathologic result used as a reference

MATERIALS AND METHODS The CT images, the 18 F-FDG PET images, and the 18 F-FET PET images The CT images, the 18 F-FDG PET images, and the 18 F-FET PET images For each patient, the observers evaluated 5 anatomic regions or levels: For each patient, the observers evaluated 5 anatomic regions or levels: level 1, nasopharynx; level 2, oropharynx; level 3, hypopharynx/larynx; region 4, right cervical lymph nodes; region 5, left cervical lymph nodes level 1, nasopharynx; level 2, oropharynx; level 3, hypopharynx/larynx; region 4, right cervical lymph nodes; region 5, left cervical lymph nodes

MATERIALS AND METHODS Each observer recorded suspected lesions and gave each level a confidence rating based on a 6-point scale, a rating score of 4 or greater was considered positive for tumor tissue Each observer recorded suspected lesions and gave each level a confidence rating based on a 6-point scale, a rating score of 4 or greater was considered positive for tumor tissue Furthermore, the maximum standardized uptake values (SUVs) in the lesions were determined Furthermore, the maximum standardized uptake values (SUVs) in the lesions were determined

INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION CONCLUSION

RESULTS In 18 of 21 patients, histologic examination revealed SCC, and in 2 of these patients, a second SCC tumor was found at a different anatomic site In 18 of 21 patients, histologic examination revealed SCC, and in 2 of these patients, a second SCC tumor was found at a different anatomic site In 3 of 21 patients, inflammatory tissue and no tumor were identified In 3 of 21 patients, inflammatory tissue and no tumor were identified

RESULTS Eighteen of 20 SCC tumors were positive for both 18 F-FDG uptake and 18 F-FET uptake, one 0.3-cm SCC tumor was detected neither with 18 F- FDG PET nor with 18 F-FET PET, and one 0.7-cm SCC tumor in a 4.3-cm ulcer was overestimated as a 4-cm tumor on 18 F-FDG PET and missed on 18 F-FET PET. Eighteen of 20 SCC tumors were positive for both 18 F-FDG uptake and 18 F-FET uptake, one 0.3-cm SCC tumor was detected neither with 18 F- FDG PET nor with 18 F-FET PET, and one 0.7-cm SCC tumor in a 4.3-cm ulcer was overestimated as a 4-cm tumor on 18 F-FDG PET and missed on 18 F-FET PET.

RESULTS 18 F-FDG PET (A), CT (B), and 18 F-FET PET (C) Images of a 52-y-old man with a 0.7-cm SCC in 4.3-cm ulcer with inflammatory tissue (arrows)

RESULTS Inflammatory tissue was positive for 18 F-FDG uptake (SUV, 3.7 – 4.7) but negative for 18 F-FET uptake (SUV, 1.3 – 1.6) Inflammatory tissue was positive for 18 F-FDG uptake (SUV, 3.7 – 4.7) but negative for 18 F-FET uptake (SUV, 1.3 – 1.6) 18 F-FDG PET (A), CT (B), and 18 F-FET PET (C)

RESULTS The SUVs of 18 F-FDG in SCC were significantly higher (13.0 ± 9.3) than those of 18 F-FET (4.4 ± 2.2) The SUVs of 18 F-FDG in SCC were significantly higher (13.0 ± 9.3) than those of 18 F-FET (4.4 ± 2.2) 18 F-FDG PET (A), CT (B), and 18 F-FET PET (C)

RESULTS In the lymph node metastases (n = 5), with an average size of 1.1 ± 0.6 cm, no increased 18 F-FET uptake could be identified (mean SUV, 1.4 ± 0.3; range, 1.0 – 1.9) In the lymph node metastases (n = 5), with an average size of 1.1 ± 0.6 cm, no increased 18 F-FET uptake could be identified (mean SUV, 1.4 ± 0.3; range, 1.0 – 1.9) The corresponding SUV for 18 F-FDG uptake ranged from 1.6 to 3.3 (mean, 2.3 ± 0.7); 2 of 5 lymph node metastases had an SUV above 2.5 and 3 of 5 had an SUV below 2.5 The corresponding SUV for 18 F-FDG uptake ranged from 1.6 to 3.3 (mean, 2.3 ± 0.7); 2 of 5 lymph node metastases had an SUV above 2.5 and 3 of 5 had an SUV below 2.5

RESULTS The sensitivity of 18 F-FDG PET was 93%, specificity was 79%, and accuracy was 83%. The sensitivity of 18 F-FDG PET was 93%, specificity was 79%, and accuracy was 83%. 18 F-FET PET yielded a lower sensitivity of 75% but a substantially higher specificity of 95% (accuracy, 90%) 18 F-FET PET yielded a lower sensitivity of 75% but a substantially higher specificity of 95% (accuracy, 90%)

RESULTS The ROC analysis showed significantly superior detection of SCC with 18 F-FET PET or 18 F-FDG PET than with CT The ROC analysis showed significantly superior detection of SCC with 18 F-FET PET or 18 F-FDG PET than with CT No significant difference (P = 0.71) was found between 18 F-FDG PET and 18 F-FET PET No significant difference (P = 0.71) was found between 18 F-FDG PET and 18 F-FET PET

INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION CONCLUSION

DISCUSSION Detection of SCC was not better with 18 F-FET PET than with 18 F-FDG PET, and no significant difference in accuracy was identified in an ROC analysis Detection of SCC was not better with 18 F-FET PET than with 18 F-FDG PET, and no significant difference in accuracy was identified in an ROC analysis The specificity of 18 F-FET PET for the detection of SCC was superior to that of 18 F-FDG PET and CT The specificity of 18 F-FET PET for the detection of SCC was superior to that of 18 F-FDG PET and CT

DISCUSSION The differences in sensitivity and specificity may be attributed partly to the relatively low 18 F-FET uptake in the tumors The differences in sensitivity and specificity may be attributed partly to the relatively low 18 F-FET uptake in the tumors This low uptake leads to a poorer detection rate, especially in small tumors, which are missed because of partial-volume effects This low uptake leads to a poorer detection rate, especially in small tumors, which are missed because of partial-volume effects

DISCUSSION Because uptake and sensitivity are lower for 18 F-FET than for 18 F-FDG, 18 F-FET does not represent an ideal tracer for the evaluation of primary SCC of the head and neck region Because uptake and sensitivity are lower for 18 F-FET than for 18 F-FDG, 18 F-FET does not represent an ideal tracer for the evaluation of primary SCC of the head and neck region

DISCUSSION The higher specificity makes 18 F-FET PET an interesting additional tool in the follow-up of patients with SCC The higher specificity makes 18 F-FET PET an interesting additional tool in the follow-up of patients with SCC Monitoring of radio- or chemotherapy of SCC, because the reaction of the tumor tissue may be specifically detected without the interfering uptake by inflammatory or reactive tissue Monitoring of radio- or chemotherapy of SCC, because the reaction of the tumor tissue may be specifically detected without the interfering uptake by inflammatory or reactive tissue

INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION CONCLUSION

18 F-FET may not replace 18 F-FDG in the PET diagnostics of head and neck cancer but may be a helpful additional tool in selected patients by allowing better differentiation of tumor tissue from inflammatory tissue 18 F-FET may not replace 18 F-FDG in the PET diagnostics of head and neck cancer but may be a helpful additional tool in selected patients by allowing better differentiation of tumor tissue from inflammatory tissue The sensitivity of 18 F-FET PET in SCC, however, was inferior to that of 18 F- FDG PET because of lower SUVs The sensitivity of 18 F-FET PET in SCC, however, was inferior to that of 18 F- FDG PET because of lower SUVs

Thank you for your attention!

18 F-FET PET Compared with 18 F- FDG PET and CT in Patients with Head and Neck Cancer Presented by Intern 羅穎駿 Journal of Nuclear Medicine Vol. 47 No © 2006